<DOC>
	<DOCNO>NCT02850029</DOCNO>
	<brief_summary>This international observational cohort study current aminoglycoside practice intensive care unit . Clinical demographic data , dose therapeutic drug monitoring data collect first week aminoglycoside ( tobramycin , amikacin gentamicin ) administration different country year . A minimum ten consecutive patient enrol site .</brief_summary>
	<brief_title>An International Survey Aminoglycoside Practices Critically Ill Patients : AMINO III Survey</brief_title>
	<detailed_description>Aminoglycosides commonly use antibiotic difficult treat infection . However , aminoglycoside administration varies widely among country . The aim multicenter observational study provide up-to-date comprehensive descriptive data current aminoglycoside ( tobramycin , amikacin gentamicin ) use large cohort critically ill patient different country . The benefit expect study well understanding worldwide aminoglycoside prescription variability critically ill patient determine risk factor inadequate aminoglycoside dose regimen .</detailed_description>
	<mesh_term>Critical Illness</mesh_term>
	<criteria>Age â‰¥ 18 year old Intensive care unit patient Receiving aminoglycoside therapy sepsis accord Third International Consensus Definitions Sepsis Septic Shock Aged &lt; 18 year age Previous inclusion study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>antimicrobial</keyword>
	<keyword>intensive care unit</keyword>
</DOC>